BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 16127361)

  • 1. Treatment of arrhythmic storm in implantable defibrillator patients.
    Krivan L; Kozák M; Sepsi M; Svobodník A; Spinar J
    Med Sci Monit; 2005 Sep; 11(9):CR426-9. PubMed ID: 16127361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Specific complications in the treatment with implantable cardioverter-defibrillators].
    Krivan L; Kozák M; Sepsi M; Svobodník A; Spinar J
    Cas Lek Cesk; 2004; 143(8):521-5; discussion 526-7. PubMed ID: 15446455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical predictors of ventricular arrhythmia storms in Chagas cardiomyopathy patients with implantable defibrillators].
    Flores-Ocampo J; Nava S; Márquez MF; Gómez-Flores J; Colín L; López A; Celaya M; Treviño E; González-Hermosillo JA; Iturralde P
    Arch Cardiol Mex; 2009; 79(4):263-7. PubMed ID: 20191986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the implantable defibrillator among elderly patients with a history of life-threatening ventricular arrhythmias.
    Healey JS; Hallstrom AP; Kuck KH; Nair G; Schron EP; Roberts RS; Morillo CA; Connolly SJ
    Eur Heart J; 2007 Jul; 28(14):1746-9. PubMed ID: 17283003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of ventricular arrhythmia burden, therapeutic interventions, and survival, in patients < 75 and patients >or= 75 years of age treated with implantable cardioverter defibrillators.
    Ermis C; Zhu AX; Vanheel L; Sakaguchi RN; Lurie KG; Lu F; Benditt DG
    Europace; 2007 May; 9(5):270-4. PubMed ID: 17371804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Electrical storm in patients with implantable cardioverter-defibrillator].
    Bárzaga FJ; Clavijo PC; Sánchez MD; Hevia JC; Molina RZ; Pérez MA; Leza JB; Rodríguez YF; Balea FD
    Arch Cardiol Mex; 2008; 78(1):68-78. PubMed ID: 18581715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is electrical storm in ICD patients the sign of a dying heart? Outcome of patients with clusters of ventricular tachyarrhythmias.
    Greene M; Newman D; Geist M; Paquette M; Heng D; Dorian P
    Europace; 2000 Jul; 2(3):263-9. PubMed ID: 11227599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical predictors and prognostic significance of electrical storm in patients with implantable cardioverter defibrillators.
    Brigadeau F; Kouakam C; Klug D; Marquié C; Duhamel A; Mizon-Gérard F; Lacroix D; Kacet S
    Eur Heart J; 2006 Mar; 27(6):700-7. PubMed ID: 16421175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of a combination of class III and class Ic antiarrhythmic agents in patients with electrical storm.
    Fuchs T; Groysman R; Meilichov I
    Pharmacotherapy; 2008 Jan; 28(1):14-9. PubMed ID: 18154469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Arrhythmic symptoms and events in patients wearing an implantable automatic defibrillator].
    Auricchio A; Auricchio U; Scafuri A; Fratini S; Chiariello L
    G Ital Cardiol; 1994 Dec; 24(12):1567-73. PubMed ID: 7883129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and causes of inappropriate detection and therapy by implantable defibrillators of cardioversion in patients with ventricular tachyarrhythmia.
    Chen RH; Chen KP; Wang FZ; Hua W; Chen X; Zhang S
    Chin Med J (Engl); 2006 Apr; 119(7):557-63. PubMed ID: 16620696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of T-wave alternans in patients with heart failure due to nonischemic cardiomyopathy: results of the ALPHA Study.
    Salerno-Uriarte JA; De Ferrari GM; Klersy C; Pedretti RF; Tritto M; Sallusti L; Libero L; Pettinati G; Molon G; Curnis A; Occhetta E; Morandi F; Ferrero P; Accardi F;
    J Am Coll Cardiol; 2007 Nov; 50(19):1896-904. PubMed ID: 17980258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylactic implantable cardioverter defibrillator therapy in dilated cardiomyopathy: impact of left ventricular function.
    Schaer BA; Ammann P; Sticherling C; Zellweger MJ; Cron TA; Osswald S
    Int J Cardiol; 2006 Mar; 108(1):26-30. PubMed ID: 16516695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy: clinical presentation, risk stratification and results of long-term follow-up.
    Pezawas T; Stix G; Kastner J; Schneider B; Wolzt M; Schmidinger H
    Int J Cardiol; 2006 Mar; 107(3):360-8. PubMed ID: 16503259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A history of heart failure predicts arrhythmia treatment efficacy: data from the Antiarrythmics versus Implantable Defibrillators (AVID) study.
    Brodsky MA; McAnulty J; Zipes DP; Baessler C; Hallstrom AP;
    Am Heart J; 2006 Oct; 152(4):724-30. PubMed ID: 16996848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hospital readmission in patients with implantable cardioverter-defibrillators.
    Kaźmierczak J; Zielonka J; Rzeuski R; Peregud-Pogorzelska M; Goracy J; Biernawska J; Sulikowski T; Kornacewicz-Jach Z
    Kardiol Pol; 2006 Jul; 64(7):684-91; discussion 692-3. PubMed ID: 16886125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical course and implantable cardioverter defibrillator therapy in postinfarction women with severe left ventricular dysfunction.
    Zareba W; Moss AJ; Jackson Hall W; Wilber DJ; Ruskin JN; McNitt S; Brown M; Wang H;
    J Cardiovasc Electrophysiol; 2005 Dec; 16(12):1265-70. PubMed ID: 16403053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infarct tissue heterogeneity assessed with contrast-enhanced MRI predicts spontaneous ventricular arrhythmia in patients with ischemic cardiomyopathy and implantable cardioverter-defibrillator.
    Roes SD; Borleffs CJ; van der Geest RJ; Westenberg JJ; Marsan NA; Kaandorp TA; Reiber JH; Zeppenfeld K; Lamb HJ; de Roos A; Schalij MJ; Bax JJ
    Circ Cardiovasc Imaging; 2009 May; 2(3):183-90. PubMed ID: 19808591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive value of programmed ventricular stimulation in patients with ischaemic cardiomyopathy: implications for the selection of candidates for an implantable defibrillator.
    De Ferrari GM; Rordorf R; Frattini F; Petracci B; De Filippo P; Landolina M
    Europace; 2007 Dec; 9(12):1151-7. PubMed ID: 17947251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of first ventricular tachycardia cycle length on rate of ventricular arrhythmia recurrence in patients with implantable cardioverter-defibrillator.
    Arya A; Haghjoo M; Nikoo MH; Dehghani MR; Fazelifar AF; Sadr-Ameli MA
    J Electrocardiol; 2006 Oct; 39(4):404-8. PubMed ID: 16895771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.